Completed
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
NCT01447914
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +38 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States